Archive: Company News

Company News: Curetis Reports Results of the Annual Shareholder Meeting Held on June 23, 2017

– Dr. Nils Clausnitzer elected as member of the Supervisory Board

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today reported the results of its Annual Shareholder Meeting (“AGM”) held in Amsterdam on June 23, 2017.

Read more…

Company News: Agena Bioscience Announces Expanded Partnership with Assurex Health

– MassArray® System Selected for Assurex Health’s GeneSight Test

Agena Bioscience today announced that Assurex Heath, a wholly owned subsidiary of Myriad Genetics, Inc., has selected the MassARRAY® System for streamlined laboratory set-up and sample processing of Assurex Health’s GeneSight test.

Read more…

Company News: Nature Medicine reports elimination of large tumors in mice by messenger RNA-encoded bispecific antibodies

– Novel mRNA-based antibody drug class holds promise for fast development of potent immunotherapies

BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, reported preclinical data featuring a novel class of mRNA-encoded antibody drugs called RiboMABs®. In Nature Medicine, BioNTech presents the application of this technology for mRNA-based in vivo delivery of T cell engaging bispecific antibodies. The study entitled “Elimination of large tumors in mice by mRNA-encoded bispecific antibodies” can be found here: http://nature.com/articles/doi:10.1038/nm.4356.

Read more…

Company News: Curetis Provides Update on Unyvero LRT FDA 510(k) Submission

Curetis reiterates that it expects FDA to provide decision on clearance of Unyvero LRT in the second half of 2017

 

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today provided an update regarding the ongoing interactive review by the U.S. Food and Drug Administration (FDA) of its 510(k) application for clearance of the Unyvero Platform and Lower Respiratory Tract Infection (LRT) Application Cartridge.

Read more…

1 2 84